Alpha-synuclein and its interplay with metals in Parkinson's disease 1=Chemical reaction dynamics and mechanisms 2=Healthcare technologies
Alpha-synuclein and its interplay with metals in Parkinson's disease 1=Chemical reaction dynamics and mechanisms 2=Healthcare technologies
批准号:
2401573
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2020
资助国家:
英国
项目状态:
未结题
起止时间:
2020 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project will extend and apply recent analytical advances in the characterization of transition metals and peptides in-vitro and in human tissue, to advance understanding of Parkinson's disease pathology [Everett et al, Nanoscale, 2018; Lermyte et al, Cells, 2019, Brooks et al, Angewandte Chemie, 2020]. The project builds directly on Bellingeri's findings in her MChem final year project work in 2018/19 [Lermyte et al, Cells 2019 and conference presentations at ASMS 2019 and BMSS 2019], and will involve collaboration between the Trace Metals in Medicine Laboratory in the School of Engineering, Warwick Chemistry, Keele University, and proposed experimental work at the Diamond Light Source synchrotron. The specific aim of this project is to determine the properties of the aggregating protein a-synuclein, especially its metal binding properties, in-vitro and where it forms aggregates in the human brain. This work will address key gaps in current understanding of the role of this protein central to Parkinson's disease pathology, provide new information about the contrast in magnetic resonance imaging arises from these aggregates, and inform therapeutic strategies with metal chelating drugs currently in clinical trials. REFERENCES [Brooks 2020] J. Brooks, J. Everett, F. Lermyte, V. Tjendana Tjhin, S. Banerjee, P.J. Sadler, P.B. O'Connor, C. Morris, N. Telling and J.F. Collingwood, Label-Free Nanoimaging of Neuromelanin in the Brain by Soft X-ray Spectromicroscopy. Angewandte Chemie International Edition. 2020 May 14; 59(29):11984-11991. [Lermyte 2019] Frederik Lermyte, James Everett, Jake Brooks, Francesca Bellingeri, Kharmen Billimoria, Peter J. Sadler, Peter B. O'Connor, Neil D. Telling, Joanna Collingwood, 'Emerging approaches to investigate the influence of transition metals in the proteinopathies', Cells 2019 Oct 10;8(10)PubMed PMID: 31658742; [Everett 2018] James Everett, Joanna F. Collingwood [corresponding author], Vindy Tjendana-Tjhin, Jake Brooks, Frederik Lermyte, Germán Plascencia-Villa, Ian Hands-Portman, Jon Dobson, George Perry and Neil D. Telling, 'Nanoscale synchrotron X-ray speciation of ferrous iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects', Nanoscale, 2018 v10, p11782-11796, https://doi.org/10.1039/C7NR06794A
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
ROS介导的α-synuclein/KLF9/PRB信号轴调控子宫内膜异位症孕激素抵抗的分子机制研究
-
批准号:2026JJ81255
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:冯力元
-
依托单位:
天麻20C通过抑制α-Synuclein聚集二次成核动力学过程发挥帕金森病治疗特色的机制研究
-
批准号:2025JJ60645
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:彭也
-
依托单位:
构建α-突触核蛋白特异性CAR-Treg治疗抗NMDAR脑炎的研究
-
批准号:2025JJ80620
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘钰
-
依托单位:
新型 DMC 结构类似物抗帕金森病中α
-synuclein 病理的作用机制研究
-
批准号:Z24H250003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张云龙
-
依托单位:
α-Synuclein 乳酸化修饰降低突触可塑性导致 POCD 的机制研究
-
批准号:24ZR1457700
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张辉
-
依托单位:
脾脏巨噬细胞功能失调介导血源性α-synuclein异构体清除障碍在PD发病中的机制研究
-
批准号:82301430
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:袁心
-
依托单位:
利用非人灵长类模型研究帕金森病致病蛋白α-synuclein的生理功能
-
批准号:32370567
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:杨伟莉
-
依托单位:
囊泡基质蛋白Chromogranin A调控α-synuclein异常聚集及其在帕金森病早期发病机制中的研究
-
批准号:82371426
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:吴齐辉
-
依托单位:
α-Synuclein通过抑制STUB1/TFEB介导的自噬促进肥胖相关的子宫内膜容受性下降的作用及机制研究
-
批准号:82301896
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:何晔
-
依托单位:
基于天然双四氢呋喃型木脂素结构的靶向α-synuclein聚集抑制的抗帕金森病先导化合物的发现研究
-
批准号:82373766
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚胜
-
依托单位: